Search Results

There are 2352 results for: content related to: Mucosal healing in Crohn's disease: A systematic review

  1. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 12, Issue 6, June 2006, Pages: 524–534, Michael R. Konikoff and Lee A. Denson

    Article first published online : 14 DEC 2006, DOI: 10.1097/00054725-200606000-00013

  2. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2218–2224, Geert D'Haens, Marc Ferrante, Severine Vermeire, Filip Baert, Maja Noman, Liesbeth Moortgat, Patricia Geens, Doreen Iwens, Isolde Aerden, Gert Van Assche, Gust Van Olmen and Paul Rutgeerts

    Article first published online : 16 FEB 2012, DOI: 10.1002/ibd.22917

  3. Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease

    Inflammatory Bowel Diseases

    Volume 14, Issue 10, October 2008, Pages: 1392–1398, Taina Sipponen, Erkki Savilahti, Päivi Kärkkäinen, Kaija-Leena Kolho, Hannu Nuutinen, Ulla Turunen and Martti Färkkilä

    Article first published online : 17 MAY 2008, DOI: 10.1002/ibd.20490

  4. Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 4, August 2015, Pages: 391–405, J. P. Gisbert, A. C. Marín and M. Chaparro

    Article first published online : 15 JUN 2015, DOI: 10.1111/apt.13276

  5. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings

    Inflammatory Bowel Diseases

    Volume 14, Issue 1, January 2008, Pages: 40–46, Taina Sipponen, Erkki Savilahti, Kaija-Leena Kolho, Hannu Nuutinen, Ulla Turunen and Martti Färkkilä

    Article first published online : 16 NOV 2007, DOI: 10.1002/ibd.20312

  6. Ulcerative colitis: Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes

    Inflammatory Bowel Diseases

    Volume 15, Issue 12, December 2009, Pages: 1851–1858, Alain M. Schoepfer, Christoph Beglinger, Alex Straumann, Michael Trummler, Pietro Renzulli and Frank Seibold

    Article first published online : 21 MAY 2009, DOI: 10.1002/ibd.20986

  7. Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 7, July 2014, Pages: 1406–1412, Keisuke Inoue, Tomoki Aomatsu, Atsushi Yoden, Takeru Okuhira, Emiri Kaji and Hiroshi Tamai

    Article first published online : 15 JUL 2014, DOI: 10.1111/jgh.12578

  8. You have free access to this content
    IBD Clinical

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue S2, October 2014, Pages: 102–123,

    Article first published online : 13 OCT 2014, DOI: 10.1111/jgh.12736_6

  9. High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6

    Clinical & Experimental Allergy

    Volume 45, Issue 5, May 2015, Pages: 928–939, L. Orivuori, K. Mustonen, M. C. de Goffau, S. Hakala, M. Paasela, C. Roduit, J.-C. Dalphin, J. Genuneit, R. Lauener, J. Riedler, J. Weber, E. von Mutius, J. Pekkanen, H. J. M. Harmsen, O. Vaarala and the PASTURE Study Group

    Article first published online : 16 APR 2015, DOI: 10.1111/cea.12522

  10. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

    Inflammatory Bowel Diseases

    Volume 15, Issue 8, August 2009, Pages: 1190–1198, Javier P. Gisbert, Fernando Bermejo, Jose-Lázaro Pérez-Calle, Carlos Taxonera, Isabel Vera, Adrian G. McNicholl, Alicia Algaba, Pilar López, Natalia López-Palacios, Marta Calvo, Yago González-Lama, Jose-Antonio Carneros, Marta Velasco and José Maté

    Article first published online : 16 MAR 2009, DOI: 10.1002/ibd.20933

  11. You have free access to this content
    Emerging role of calprotectin in gastroenterology

    Journal of Gastroenterology and Hepatology

    Volume 18, Issue 7, July 2003, Pages: 756–762, ANDREW POULLIS, RUSSELL FOSTER, MICHAEL A MENDALL and MAGNE K FAGERHOL

    Article first published online : 10 JUN 2003, DOI: 10.1046/j.1440-1746.2003.03014.x

  12. You have free access to this content
    Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 10, November 2008, Pages: 1221–1229, T. SIPPONEN, P. KÄRKKÄINEN, E. SAVILAHTI, K.-L. KOLHO, H. NUUTINEN, U. TURUNEN and M. FÄRKKILÄ

    Article first published online : 26 AUG 2008, DOI: 10.1111/j.1365-2036.2008.03835.x

  13. Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents

    Inflammatory Bowel Diseases

    Volume 18, Issue 11, November 2012, Pages: 2011–2017, Pauliina Molander, Clas-Göran af Björkesten, Harri Mustonen, Johanna Haapamäki, Matti Vauhkonen, Kaija-Leena Kolho, Martti Färkkilä and Taina Sipponen

    Article first published online : 4 JAN 2012, DOI: 10.1002/ibd.22863

  14. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis

    Liver International

    Volume 31, Issue 9, October 2011, Pages: 1406–1415, Felix Gundling, Fabian Schmidtler, Alexander Hapfelmeier, Benjamin Schulte, Thomas Schmidt, Christian Pehl, Wolfgang Schepp and Holger Seidl

    Article first published online : 6 SEP 2011, DOI: 10.1111/j.1478-3231.2011.02577.x

  15. You have free access to this content
    Update of fecal markers of inflammation in inflammatory bowel disease

    Journal of Gastroenterology and Hepatology

    Volume 26, Issue 10, October 2011, Pages: 1493–1499, Thomas A Judd, Andrew S Day, Daniel A Lemberg, Dan Turner and Steven T Leach

    Article first published online : 22 SEP 2011, DOI: 10.1111/j.1440-1746.2011.06846.x

  16. You have free access to this content
    Postoperative recurrent luminal Crohn's Disease: A systematic review

    Inflammatory Bowel Diseases

    Volume 18, Issue 4, April 2012, Pages: 758–777, Peter De Cruz, Michael A. Kamm, Lani Prideaux, Patrick B. Allen and Paul V. Desmond

    Article first published online : 9 AUG 2011, DOI: 10.1002/ibd.21825

  17. You have free access to this content
    Undetectable anti-TNF drug levels in patients with long-term remission predict successful drug withdrawal

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 3, August 2015, Pages: 356–364, S. Ben-Horin, Y. Chowers, B. Ungar, U. Kopylov, R. Loebstein, B. Weiss, R. Eliakim, E. Del Tedesco, S. Paul and X. Roblin

    Article first published online : 1 JUN 2015, DOI: 10.1111/apt.13268

  18. Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 8, August 2012, Pages: 1493–1497, Ron Shaoul, Marlgozata Sladek, Dan Turner, Anders Paeregaard, Gabor Veres, Gigi Veereman Wauters, Johanna Escher, Jorge Amil Dias, Paolo Lionetti, Annamaria Staino, Kaija Leena Kolho, Lissy de Ridder, Federica Nuti, Salvatore Cucchiara, Orit Sheva, Arie Levine and and the ESPGHAN Porto IBD Group

    Article first published online : 24 JAN 2012, DOI: 10.1002/ibd.21875

  19. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control

    Inflammatory Bowel Diseases

    Volume 18, Issue 11, November 2012, Pages: 2018–2025, Patrick F. van Rheenen

    Article first published online : 24 JAN 2012, DOI: 10.1002/ibd.22896

  20. You have free access to this content
    Practical application of anti-TNF therapy for luminal Crohn's disease

    Inflammatory Bowel Diseases

    Volume 17, Issue 11, November 2011, Pages: 2366–2391, Michael A. Kamm, Siew C. Ng, Peter De Cruz, Patrick Allen and Stephen B. Hanauer

    Article first published online : 18 FEB 2011, DOI: 10.1002/ibd.21655